Recorded fact · drug.label_indication

drug.label_indication for empagliflozin-metformin-hcl|type-2-diabetes

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 8395bac8 resolves to.

The record

Fact id	`8395bac895c49130a45352b5`
Entity	drug: empagliflozin-metformin-hcl\|type-2-diabetes
Field	drug.label_indication
Source	api.fda.gov
Read on	2026-11-10T19:02:47.536Z
Source version	openfda-label-20260825
Method	extract
Verification	verified
Licence	CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels
Edition	2026-11, Merkle root `006ab9a329709cbe...`

The verifying quote

nd metformin hydrochloride (HCl) immediate-release, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

Shown with dashes as hyphens. SHA-256 of the exact stored quote: ce0c54014e7dd0718b345e26f07d2fe7f286d870e67a9ea4f80a9de3fab7ca6b.

The value

{
 "ingredient": "Empagliflozin/Metformin HCl",
 "conditionId": "type-2-diabetes",
 "conditionName": "Type 2 diabetes",
 "matchedAlias": "type 2 diabetes",
 "context": "indication",
 "brand": "Synjardy",
 "identifiedVia": "generic_name",
 "extractor": 5,
 "labelSetId": "0fdd0255-0055-65f3-b2c0-db8fbb87beae",
 "labelEffectiveTime": "20260825",
 "labelsRead": 2,
 "labelsNaming": 2,
 "registryEditionRoot": "1b44e76f5da1a417",
 "meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}

SHA-256 of the exact stored value: 6c65406ef3685d30b5a3c280516ab683ce8c838cbd78d22fc8782321434b49dd.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.